Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (2) Birchmeier, Walter Prof. Dr. (1) Bunse, Mario Dr. (1) Cakmak-Görür, Nese Dr. (1) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (2) Dörr, Jan Rafael (1) Fielitz, Jens Dr. (1) Kammertöns, Thomas Dr. (13) Kettenmann, Helmut Prof. Dr. (1) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Na, Il-Kang Dr. (1) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (5) Poncette, Lucia (1) Rhein, Simone Dr. (1) Schmitt, Clemens Prof. Dr. (22) Siffrin, Volker (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (8) Willimsky, Gerald Dr. (6) Wolf, Susanne Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (37) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) (-) 2004 (8) (-) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) (-) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) (-) 2016 (4) 2017 (7) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (7) 2023 (5) 2024 (2) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (18) (-) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (2) Immune Regulation and Cancer (2) (-) Molecular Immunology and Gene Therapy (37) Proteome Dynamics (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) Translational Bioinformatics (2) 37 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Cancer Genetics and Cellular Stress ResponsesMolecular Immunology and Gene Therapy200420052012201520162019 Sort: Result score Newest to oldest Oldest to newest December 01, 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens November 01, 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein October 01, 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein April 01, 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee March 30, 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm October 01, 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule September 02, 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule February 07, 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
December 01, 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
November 01, 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein
October 01, 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein
April 01, 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee
March 30, 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
October 01, 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein
November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
September 02, 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule
February 07, 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler
March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann